Patient adherence behavior change engine.
Care coordination, treatment adherence and CMS STAR programs are some of the clinically driven business requirements we solve for. See how we've grown and validated dozens of patient engagement and decision support programs for our global partners.
Get the Lit Review of all things MEMOTEXTIntegrated in provider, insurance, pharmaceutical and pharmacy support settings, we use medical and prescription claims data, EMRs, wearables and patient reported outcomes to identify risk and personalize communications.
Using advanced analytics, voice assistants (Alexa), SMS messaging, IVRs and iOS/Android applications, MEMOTEXT learns and optimizes communications to improve adherence to treatment, care-coordination and sustained behavior change.
Every program, application or intervention starts with a clinically-driven business need. What do you need to accomplish? What needs to be changed?
Use cases:
Your patients are unique and so are the interventions that they will engage best with. By analyzing and actioning health data, we can provide insights into specific characteristics of patient populations to enable precision targeting, ensuring the right person receives the right content at the right time.
This is the first step in our evidence-based approach to digital engagement.
Our platform helps to drive outcomes, whether they be specific to medication adherence, lifestyle change, or increasing health knowledge. With the right content and expertise backing your intervention, look forward to improved patient experiences and outcomes that will greatly benefit your bottom line. Reporting solutions will help you track the progress and engagement levels to ensure that KPIs are being met.
Read about our digital health intervention for glaucoma patients, where we saw a 31.4% increase in medication adherence.
Learn about Ring of Support! Our program helps to provide independence and peace of mind.
A4i, our digital therapeutic, has shown significant improvement in some psychiatric symptom domains for individuals suffering from schizophrenia.
Made for MEMOTEXT © 2019